Patents by Inventor Wagner José FAVARO

Wagner José FAVARO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for producing a nanostructured complex (CFI-1), a protein-associated nanostructured complex (MRB-CFI-1) and use
    Patent number: 11639294
    Abstract: Disclosed is a method for treating cancer in a subject by administering to the subject a compound selected from NH4MgPO4×6H2O, (NH4)2MgH2(PO4)2×4H2O, (NH4)2Mg3(HPO4)4×8H2O and NH4MgPO4×H2O associated or not to hydrolytic enzymes, which are known to have immunomodulatory activities.
    Type: Grant
    Filed: April 21, 2021
    Date of Patent: May 2, 2023
    Inventors: Wagner José Favaro, Nelson Eduardo Duran Caballero
  • Method for producing a nanostructured complex (CFI-1), a protein-associated nanostructured complex (MRB-CFI-1) and use
    Patent number: 11623869
    Abstract: Disclosed is a method of obtaining an inorganic nanostructured complex (CFI-1) by chemical synthesis and antitumor use. The main use is in treating cancer, both in animals and humans. The complex has singular antitumor activity, and can potentially be used as a substitute and/or act as an adjuvant for other commercial antineoplastic drugs.
    Type: Grant
    Filed: April 21, 2021
    Date of Patent: April 11, 2023
    Inventors: Wagner José Favaro, Nelson Eduardo Duran Caballero
  • Method for producing a nanostructured complex (CFI-1), a protein-associated nanostructured complex (MRB-CFI-1) and use
    Patent number: 11572284
    Abstract: Disclosed is a method of obtaining a protein-associated nanostructured complex (MRB-CFI-1) by chemical synthesis and antitumor use. The main use is in treating cancer, both in animals and humans. The complex has singular antitumor activity, and can potentially be used as a substitute and/or act as an adjuvant for other commercial antineoplastic drugs.
    Type: Grant
    Filed: April 21, 2021
    Date of Patent: February 7, 2023
    Inventors: Wagner José Favaro, Nelson Eduardo Duran Caballero
  • Method for producing a nanostructured complex (CFI-1), a protein-associated nanostructured complex (MRB-CFI-1) and use
    Patent number: 11136242
    Abstract: Disclosed is a method of obtaining an inorganic nanostructured complex (CFI-1), a protein-associated nanostructured complex (MRB-CFI-1) and antitumor use. The main use is in treating urinary bladder cancer, both in animals and humans. The complex has singular antitumor activity, and can potentially be used as a substitute and/or act as an adjuvant for other commercial antineoplastic drugs.
    Type: Grant
    Filed: June 14, 2018
    Date of Patent: October 5, 2021
    Inventors: Wagner José Favaro, Nelson Eduardo Duran Caballero
  • METHOD FOR PRODUCING A NANOSTRUCTURED COMPLEX (CFI-1), A PROTEIN-ASSOCIATED NANOSTRUCTURED COMPLEX (MRB-CFI-1) AND USE
    Publication number: 20210238044
    Abstract: Disclosed is a method of obtaining an inorganic nanostructured complex (CFI-1) by chemical synthesis and antitumor use. The main use is in treating cancer, both in animals and humans. The complex has singular antitumor activity, and can potentially be used as a substitute and/or act as an adjuvant for other commercial antineoplastic drugs.
    Type: Application
    Filed: April 21, 2021
    Publication date: August 5, 2021
    Inventors: Wagner José FAVARO, Nelson Eduardo Duran CABALLERO
  • METHOD FOR PRODUCING A NANOSTRUCTURED COMPLEX (CFI-1), A PROTEIN-ASSOCIATED NANOSTRUCTURED COMPLEX (MRB-CFI-1) AND USE
    Publication number: 20210238045
    Abstract: Disclosed is a method of obtaining a protein-associated nanostructured complex (MRB-CFI-1) by chemical synthesis and antitumor use. The main use is in treating cancer, both in animals and humans. The complex has singular antitumor activity, and can potentially be used as a substitute and/or act as an adjuvant for other commercial antineoplastic drugs.
    Type: Application
    Filed: April 21, 2021
    Publication date: August 5, 2021
    Inventors: Wagner José FAVARO, Nelson Eduardo Duran CABALLERO
  • METHOD FOR PRODUCING A NANOSTRUCTURED COMPLEX (CFI-1), A PROTEIN-ASSOCIATED NANOSTRUCTURED COMPLEX (MRB-CFI-1) AND USE
    Publication number: 20210238046
    Abstract: Disclosed is a method for treating cancer in a subject by administering to the subject a compound selected from NH4MgPO4×6H2O, (NH4)2MgH2(PO4)2×4H2O, (NH4)2Mg3(HPO4)4×8H2O and NH4MgPO4×H2O associated or not to hydrolytic enzymes, which are known to have immunomodulatory activities.
    Type: Application
    Filed: April 21, 2021
    Publication date: August 5, 2021
    Inventors: Wagner José FAVARO, Nelson Eduardo Duran CABALLERO
  • A METHOD FOR PRODUCING A NANOSTRUCTURED COMPLEX (CFI-1), A PROTEIN-ASSOCIATED NANOSTRUCTURED COMPLEX (MRB-CFI-1) AND USE
    Publication number: 20200156951
    Abstract: Disclosed is a method of obtaining an inorganic nanostructured complex (CFI-1), a protein-associated nanostructured complex (MRB-CFI-1) and antitumor use. The main use is in treating urinary bladder cancer, both in animals arid humans. The complex has singular antitumor activity, and can potentially be used as a substitute and/or act as an adjuvant for other commercial antineoplastic drugs.
    Type: Application
    Filed: June 14, 2018
    Publication date: May 21, 2020
    Inventors: Wagner José FAVARO, Nelson Eduardo Duran CABALLERO